get a key
steadybase-$ company AVTX
account_id none on file
legal_name Avalo Therapeutics, Inc.
ticker AVTX
cik 1534120
domain avalotx.com
entry_point_account_id none on file
name Avalo Therapeutics Inc.
exchange Nasdaq
sector Health Care
hq Wayne, PA, United States
calls 0 filings 22 executives 4 family 0
why_nownone on file
callsnone on file
filings
Additionally, Avalo had an operating lease for administrative office space in Rockville, Maryland, which the Company elected to early-terminate effective January 31, 2026 by providing notice and paying the $ 0.3 million contractual early termination fee in the fourth quarter of 2024, resulting in a remeasurement and reduction of the lease liability and right-of-use (“ROU”) asset by $ 0.3 million.

filing / Aug 6, 2026 / receipt

Salaries, benefits and related costs increased $0.7 million compared to the three months ended March 31, 2025 due primarily to headcount additions during the year.

filing / May 13, 2026 / receipt

The increase in general and administrative expenses from the prior year period was driven by a $0.6 million increase in salaries, benefits and related costs compared to the prior year due primarily to headcount additions.

filing / May 13, 2026 / receipt

Additionally, Avalo had an operating lease for administrative office space in Rockville, Maryland, which the Company elected to early-terminate effective January 31, 2026 by providing notice and paying the $ 0.3 million contractual early termination fee in the fourth quarter of 2024, resulting in a remeasurement and reduction of the lease liability and right-of-use (“ROU”) asset by $ 0.3 million.

filing / May 13, 2026 / receipt

Sr. Manager, Quality Systems and Compliance Technology | {"ats": "greenhouse", "city": "Chesterbrook", "state": "PA", "job_id": "4341798009", "remote": false, "category": "other", "function": "legal",

company_statement / Sep 16, 2026 / receipt

Director Analytical Development | {"ats": "greenhouse", "city": "Chesterbrook", "state": "PA", "job_id": "4396185009", "remote": false, "category": "other", "function": "other", "location": "Chesterbr

company_statement / Sep 10, 2026 / receipt

Dir./Sr. Director, Upstream Biologics Manufacturing | {"ats": "greenhouse", "city": "Chesterbrook", "state": "PA", "job_id": "4394253009", "remote": false, "category": "other", "function": "other", "l

company_statement / Sep 4, 2026 / receipt

Dir./Sr. Director, Downstream Biologics Manufacturing | {"ats": "greenhouse", "city": "Chesterbrook", "state": "PA", "job_id": "4394275009", "remote": false, "category": "other", "function": "other",

company_statement / Sep 4, 2026 / receipt

Senior Manager, SEC Reporting | {"ats": "greenhouse", "city": "Chesterbrook", "state": "PA", "job_id": "4375281009", "remote": false, "category": "other", "function": "other", "location": "Chesterbroo

company_statement / Aug 21, 2026 / receipt

Supply Chain Lead | {"ats": "greenhouse", "city": "Chesterbrook", "state": "PA", "job_id": "4375305009", "remote": false, "category": "other", "function": "operations", "location": "Chesterbrook, PA",

company_statement / Aug 20, 2026 / receipt

Medical Director/Sr. Medical Director, Clinical Development- Dermatology | {"ats": "greenhouse", "city": "Chesterbrook", "state": "PA", "job_id": "4360075009", "remote": false, "category": "other", "f

company_statement / Aug 13, 2026 / receipt

Sr. Clinical Scientist | {"ats": "greenhouse", "city": "Chesterbrook", "state": "PA", "job_id": "4360685009", "remote": false, "category": "other", "function": "clinical", "location": "Chesterbrook, P

company_statement / Aug 10, 2026 / receipt

executives
Garry A. Neil President and Chief Executive Officer - receipt
Michael Cola Chairman of the Board - receipt
Peter Greenleaf Chief Executive Officer - receipt
Simon Pedder Executive Chairman of the Board - receipt
familynone on file
upcoming
2026-11-05 earnings call scheduled ir
changes
2022-02-18 President and Chief Executive Officer, appointed sec_8k
2022-02-08 Chief Medical Officer, departed sec_8k
2021-06-21 Chairman of the Board, appointed sec_8k
2019-04-12 Executive Chairman of the Board, appointed sec_8k
2018-07-16 Chief Financial Officer, departed sec_8k
2018-04-02 Chief Executive Officer, appointed sec_8k
mcp_package_hint
steadybase-$